Wellfully Ltd
Wellfully Limited, together with its subsidiaries, engages in the research and development of Dermaportation and ETP transdermal drug delivery technologies. The company operates through two segments, Dermaportation Drug Delivery Technology and Devices. It is involved in the industrialization and supply-chain support for its existing product ranges; and sale and marketing of its own brands REDUIT … Read more
Wellfully Ltd (WFL) - Net Assets
Latest net assets as of December 2023: AU$-1.69 Million AUD
Based on the latest financial reports, Wellfully Ltd (WFL) has net assets worth AU$-1.69 Million AUD as of December 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$3.51 Million) and total liabilities (AU$5.20 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$-1.69 Million |
| % of Total Assets | -48.09% |
| Annual Growth Rate | N/A |
| 5-Year Change | -167.18% |
| 10-Year Change | -144.66% |
| Growth Volatility | 273.24 |
Wellfully Ltd - Net Assets Trend (1998–2022)
This chart illustrates how Wellfully Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Wellfully Ltd (1998–2022)
The table below shows the annual net assets of Wellfully Ltd from 1998 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | AU$-1.71 Million | -376.02% |
| 2021-12-31 | AU$619.56K | -73.16% |
| 2020-12-31 | AU$2.31 Million | +289.38% |
| 2019-12-31 | AU$-1.22 Million | -147.89% |
| 2018-12-31 | AU$2.55 Million | -40.18% |
| 2017-12-31 | AU$4.26 Million | -25.37% |
| 2016-12-31 | AU$5.70 Million | -21.63% |
| 2015-12-31 | AU$7.28 Million | +104.28% |
| 2014-12-31 | AU$3.56 Million | -6.99% |
| 2013-12-31 | AU$3.83 Million | +18.91% |
| 2012-12-31 | AU$3.22 Million | -2.46% |
| 2011-12-31 | AU$3.30 Million | -26.37% |
| 2010-12-31 | AU$4.48 Million | -11.13% |
| 2009-12-31 | AU$5.04 Million | +1094.76% |
| 2008-12-31 | AU$422.24K | -62.70% |
| 2007-12-31 | AU$1.13 Million | -39.03% |
| 2006-12-31 | AU$1.86 Million | +223.06% |
| 2005-12-31 | AU$574.71K | -53.24% |
| 2004-12-31 | AU$1.23 Million | +36.02% |
| 2003-12-31 | AU$903.54K | +175.47% |
| 2002-12-31 | AU$-1.20 Million | -434.53% |
| 2001-12-31 | AU$357.87K | -89.21% |
| 2000-12-31 | AU$3.32 Million | -63.06% |
| 1999-12-31 | AU$8.98 Million | +21.91% |
| 1998-12-31 | AU$7.37 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Wellfully Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 80244.9% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$51.72 Million | % |
| Other Comprehensive Income | AU$1.07 Million | % |
| Total Equity | AU$-1.71 Million | 100.00% |
Wellfully Ltd Competitors by Market Cap
The table below lists competitors of Wellfully Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ARC MINERALS LTD
F:DFYA
|
$728.45K |
|
Dermata Therapeutics Inc
NASDAQ:DRMA
|
$728.51K |
|
Jwwinvest
WAR:JWW
|
$728.66K |
|
NSTAR Electric Company
PINK:NSARO
|
$728.99K |
|
ENTERGY
BE:ETY
|
$727.31K |
|
ECHO GLBL LOGST
BE:AINN
|
$727.19K |
|
YY Group Holding Limited Class A Ordinary Shares
NASDAQ:YYGH
|
$727.17K |
|
DANIMER SCIENTIFIC
F:6CU
|
$727.13K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Wellfully Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 619,557 to -1,710,132, a change of -2,329,689 (-376.0%).
- Net loss of 6,354,783 reduced equity.
- Share repurchases of 448,677 reduced equity.
- New share issuances of 3,600,979 increased equity.
- Other comprehensive income increased equity by 432,870.
- Other factors increased equity by 439,922.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-6.35 Million | -371.6% |
| Share Repurchases | AU$448.68K | -26.24% |
| Share Issuances | AU$3.60 Million | +210.57% |
| Other Comprehensive Income | AU$432.87K | +25.31% |
| Other Changes | AU$439.92K | +25.72% |
| Total Change | AU$- | -376.02% |
Book Value vs Market Value Analysis
This analysis compares Wellfully Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-12-31 | AU$67.02 | AU$0.00 | x |
| 1999-12-31 | AU$81.71 | AU$0.00 | x |
| 2000-12-31 | AU$2.94 | AU$0.00 | x |
| 2001-12-31 | AU$0.29 | AU$0.00 | x |
| 2002-12-31 | AU$-0.98 | AU$0.00 | x |
| 2003-12-31 | AU$0.08 | AU$0.00 | x |
| 2004-12-31 | AU$0.06 | AU$0.00 | x |
| 2005-12-31 | AU$0.02 | AU$0.00 | x |
| 2006-12-31 | AU$0.07 | AU$0.00 | x |
| 2007-12-31 | AU$0.04 | AU$0.00 | x |
| 2008-12-31 | AU$0.01 | AU$0.00 | x |
| 2009-12-31 | AU$0.09 | AU$0.00 | x |
| 2010-12-31 | AU$0.07 | AU$0.00 | x |
| 2011-12-31 | AU$0.05 | AU$0.00 | x |
| 2012-12-31 | AU$0.05 | AU$0.00 | x |
| 2013-12-31 | AU$0.05 | AU$0.00 | x |
| 2014-12-31 | AU$0.04 | AU$0.00 | x |
| 2015-12-31 | AU$0.07 | AU$0.00 | x |
| 2016-12-31 | AU$0.05 | AU$0.00 | x |
| 2017-12-31 | AU$0.04 | AU$0.00 | x |
| 2018-12-31 | AU$0.02 | AU$0.00 | x |
| 2019-12-31 | AU$-0.01 | AU$0.00 | x |
| 2020-12-31 | AU$0.01 | AU$0.00 | x |
| 2021-12-31 | AU$0.00 | AU$0.00 | x |
| 2022-12-31 | AU$0.00 | AU$0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Wellfully Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -421.46%
- • Asset Turnover: 0.43x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-162.35%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1999 | 16.40% | 0.00% | 0.00x | 1.26x | AU$574.76K |
| 2000 | -170.70% | 0.00% | 0.00x | 1.63x | AU$-6.00 Million |
| 2001 | -827.12% | -71.10% | 1.59x | 7.34x | AU$-3.00 Million |
| 2002 | 0.00% | -77.30% | 3.35x | 0.00x | AU$-1.44 Million |
| 2003 | 79.81% | 0.00% | 0.00x | 1.01x | AU$630.76K |
| 2004 | -100.45% | 0.00% | 0.00x | 1.11x | AU$-1.36 Million |
| 2005 | -249.36% | 0.00% | 0.00x | 1.12x | AU$-1.49 Million |
| 2006 | -75.22% | -1168.71% | 0.06x | 1.16x | AU$-1.58 Million |
| 2007 | -81.76% | -123.34% | 0.49x | 1.36x | AU$-1.04 Million |
| 2008 | -410.33% | -370.17% | 0.30x | 3.67x | AU$-1.77 Million |
| 2009 | -18.93% | -119.25% | 0.14x | 1.10x | AU$-1.46 Million |
| 2010 | -20.02% | -149.25% | 0.12x | 1.10x | AU$-1.35 Million |
| 2011 | -42.75% | -271.91% | 0.14x | 1.13x | AU$-1.74 Million |
| 2012 | -41.35% | -197.81% | 0.19x | 1.13x | AU$-1.65 Million |
| 2013 | -57.59% | -273.38% | 0.19x | 1.12x | AU$-2.59 Million |
| 2014 | -64.55% | -164.85% | 0.34x | 1.16x | AU$-2.66 Million |
| 2015 | -48.87% | -265.45% | 0.17x | 1.08x | AU$-4.28 Million |
| 2016 | -97.10% | -335.49% | 0.27x | 1.09x | AU$-6.11 Million |
| 2017 | -39.92% | -160.77% | 0.22x | 1.13x | AU$-2.12 Million |
| 2018 | -67.18% | -136.87% | 0.40x | 1.23x | AU$-1.96 Million |
| 2019 | 0.00% | -626.21% | 0.48x | 0.00x | AU$-3.45 Million |
| 2020 | -277.10% | -1381.78% | 0.14x | 1.47x | AU$-6.63 Million |
| 2021 | -1302.27% | -310.34% | 0.99x | 4.23x | AU$-8.13 Million |
| 2022 | 0.00% | -421.46% | 0.43x | 0.00x | AU$-6.18 Million |
Industry Comparison
This section compares Wellfully Ltd's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $159,525,356
- Average return on equity (ROE) among peers: -28.26%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Wellfully Ltd (WFL) | AU$-1.69 Million | 16.40% | N/A | $727.70K |
| Australian Clinical Labs Ltd (ACL) | $68.99 Million | 59.80% | 4.31x | $217.50 Million |
| Bcal Diagnostics Ltd (BDX) | $6.22 Million | -116.40% | 0.59x | $10.33 Million |
| Capitol Health Ltd (CAJ) | $144.04 Million | 0.60% | 0.82x | $222.66 Million |
| Cryosite Ltd (CTE) | $1.45 Million | 126.98% | 12.60x | $5.03 Million |
| Genetic Signatures Ltd (GSS) | $16.18 Million | -10.68% | 0.02x | $8.20 Million |
| Healius Ltd (HLS) | $1.04 Billion | -62.05% | 1.87x | $208.81 Million |
| Inoviq Ltd (IIQ) | $2.83 Million | -115.42% | 0.16x | $23.33 Million |
| Microba Life Sciences Ltd (MAP) | $32.49 Million | -45.98% | 0.46x | $10.42 Million |
| Monash Ivf Group Ltd (MVF) | $268.44 Million | 9.37% | 0.33x | $116.82 Million |
| Pacific Edge Ltd (PEB) | $13.91 Million | -128.81% | 0.19x | $89.67 Million |